<DOC>
	<DOCNO>NCT01275300</DOCNO>
	<brief_summary>We would like see aspirin could block niacin-induced flushing analyze blood urine take aspirin . Phase I : 5 day 81 mg aspirin/placebo follow 600 mg Niacin , 2 week washout 5 day take alternate . The order give randomize assigned chance . Phase II : One study week consist 5 day take 81 mg Aspirin , take daily , follow single dose 600 mg Niacin day 6 . Phase III : 5 day take 81 mg Aspirin/placebo , 10 day washout . Phase IV : Use extend release niacin instead instant release . Phase V : A Celebrex study necessary explore contribution Cox-2 niacin induce flushing .</brief_summary>
	<brief_title>Biosynthesis PGD2 Vivo</brief_title>
	<detailed_description>The purpose study look roles various blood cell contribution different prostaglandin . The intention well understanding prostaglandins various metabolite , provide insight roles cardiovascular system . Prostaglandins metabolite naturally occur substance find blood urine act marker quantify study study . Flushing response niacin also assess laser doppler measuring blood flow facial skin . Untransformed transform data subject exploratory analysis variance appropriate three factor design one two period crossover factor two non-repeated factor . Additionally , volunteer 's test ( ) pair observation characterize magnitude niacin effect response variable within select time point .</detailed_description>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>age 1870 subject must good health base medical history All subject must nonsmoking , nonpregnant volunteer Female subject child bear potential must use medically acceptable method contraception throughout entire study period . All female subject must consent urine pregnancy test screen prior start treatment period study , must negative time point . subject medical condition accord investigator may interfere interpretation study result , indicative underlying disease state , compromise safety potential subject . subject receive experimental drug within 30 day prior study . subject take medication least 10 day prior study . Birth Control pills acceptable shall exclude . Subjects take aspirin aspirin contain product least 10 day prior study . Subjects take acetaminophen , NSAIDS , COX2 inhibitor ( OTC prescription ) least 10 day prior study . Subjects currently consume type tobacco product ( ) . Subjects consume high dos antioxidant vitamin daily ( vitamin C &gt; 1000mg , Vitamin E &gt; 400 IU , Beta Carotene &gt; 1000IU , Vitamin A &gt; 5000IU , Selenium &gt; 200mcg , Folic Acid &gt; 1mg ) 2 week prior start study throughout study . Subjects consume alcohol , caffeine high fat food 24 hour prior study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>